Value, Quality, Momentum, And Lower Volatility In One Emerging Markets Fund

Photo of Omor Ibne Ehsan
By Omor Ibne Ehsan Published

Quick Read

  • Fidelity Emerging Markets Multifactor ETF (FDEM) returned 52% over five years versus 34% for iShares MSCI Emerging Markets ETF (EEM), outperforming through full market cycles by screening for value, quality, momentum, and lower volatility while de-emphasizing stocks correlated to the S&P 500. Vanguard FTSE Emerging Markets ETF (VWO) remains the low-cost alternative for investors prioritizing pure expense ratios over factor tilts.

  • FDEM lags during momentum-driven rallies when mega-cap tech names like Taiwan Semiconductor, Tencent, and Alibaba dominate, but its factor discipline delivers better risk-adjusted returns across full cycles including drawdowns when quality and lower volatility screens protect capital.

  • The analyst who called NVIDIA in 2010 just named his top 10 stocks and Fidelity Emerging Markets Multifactor ETF wasn't one of them. Get them here FREE.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Value, Quality, Momentum, And Lower Volatility In One Emerging Markets Fund

© tadamichi / Shutterstock.com

Emerging markets investing has a recurring frustration. You buy the asset class for diversification and growth, then find that a handful of state-owned banks, commodity giants, and speculative tech names dominate the index. Fidelity Emerging Markets Multifactor ETF (NYSEARCA:FDEM) tries to fix that by screening the same universe through four lenses at once, value, quality, momentum, and lower volatility, with an added tilt toward stocks less correlated to U.S. equities.

That is a more sophisticated pitch than a market-cap-weighted scoop of everything trading in Mumbai, Taipei, and Sao Paulo. The question is whether the factor recipe earns its keep against a plain index, especially in a year when the asset class is finally working again.

What FDEM Is Built To Do

The fund targets large- and mid-cap emerging market equities and reweights them based on factor scores. Quality screens for durable margins and clean balance sheets. Value tilts toward cheaper cash flows. Momentum captures stocks already trending. Lower volatility damps the worst drawdowns. The lower-correlation overlay is the part most investors miss. It actively de-emphasizes EM names that move in lockstep with the S&P 500, which is the entire reason you bought emerging markets in the first place.

Conceptually, the return engine is straightforward. You own a portfolio of operating businesses whose cash flows compound, and you trust that systematic factor selection improves the odds of capturing winners while sidestepping value traps and blow-ups. Fidelity is essentially selling discipline. The strategy buys what the screens say to buy, not what the headlines say to chase.

Does The Strategy Actually Deliver?

Performance in 2026 tells a complicated story. FDEM is up 14% year to date and 39% over the past year, with shares around $35. Those are real numbers in a real EM rally.

The honest comparison is the iShares MSCI Emerging Markets ETF (NYSEARCA:EEM | EEM Price Prediction), which is up 17% year-to-date and 46% over the past year. Plain EM beat the multifactor version when the rally was driven by exactly the names you would expect, Taiwan Semiconductor, Tencent, and Alibaba, all heavy momentum and quality names that any factor screen should pick up.

Stretch the window and the picture flips. FDEM has returned 52% over five years, while EEM is up 34% over the same stretch. That is the multifactor methodology earning its fee through a full cycle that included a brutal 2022 and a rolling EM drawdown, exactly the environments where lower volatility and quality screens are supposed to matter.

The Tradeoffs You Inherit

Three constraints are worth your attention before you size a position.

  1. Scale and cost relative to alternatives. FDEM remains a small fund with a niche following. Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) is the obvious low-cost benchmark, and investors prioritizing pure cost and liquidity over factor tilts will find it hard to justify paying up for a screen they could approximate.
  2. Lumpy, unpredictable income. The fund paid $0.277 per share in late April 2026 after distributing $0.343 per share in June 2025. Distributions are irregular, which makes FDEM a poor fit for anyone trying to engineer a steady income stream.
  3. Macro sensitivity you cannot screen away. EM returns still hinge on the dollar and global rates. The 10-year Treasury sits at 4.4%, near the top of its 12-month range, while the dollar trades at about 1.18 against the euro, near the top of its recent range. Neither setup is friendly to EM. Factor tilts soften that pressure. They do not eliminate it.

Where It Fits

FDEM makes sense as a 5-10% diversifying sleeve for investors who want emerging markets exposure without the index’s worst concentration habits, particularly those willing to accept short stretches of underperformance versus EEM during momentum-driven rallies in exchange for steadier full-cycle results. The primary risk is the one you signed up for, a strong dollar and rising real rates can still drag the whole asset class down regardless of how cleverly the factors are stacked.

Photo of Omor Ibne Ehsan
About the Author Omor Ibne Ehsan →

Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks.

Continue Reading

Top Gaining Stocks

ENPH Vol: 20,331,230
DXCM Vol: 11,133,392
FDS Vol: 1,192,775
WDAY Vol: 5,160,389
NOW Vol: 34,569,747

Top Losing Stocks

CTRA Vol: 73,319,495
GLW Vol: 17,221,470
COIN Vol: 14,429,129
F Vol: 108,272,348
MU Vol: 48,532,352